{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:48:17Z","timestamp":1762876097002},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Submental fat (SMF) can negatively affect perceptions of health and attractiveness. The Condition of Submental Fullness and Treatment Outcomes Registry (CONTOUR) was designed to understand SMF treatment in clinical practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To report efficacy, treatment characteristics, and safety associated with real-world use of ATX-101 (deoxycholic acid injection).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>CONTOUR enrolled adults considering treatment for SMF reduction. ATX-101\u2013treated patients who completed the end-of-treatment questionnaire were divided into those who ended treatment because they met their treatment goals (<jats:italic toggle=\"yes\">n<\/jats:italic> = 197) and those who did not (<jats:italic toggle=\"yes\">n<\/jats:italic> = 196).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Patients who met their goals (a more defined jawline, looking younger, and looking thinner) were more likely to have less SMF at baseline and to receive \u22652 ATX-101 treatments. More patients who met their goals achieved clinically meaningful reduction in SMF and reported increased satisfaction with their appearance (90% vs 57%). Moderate and severe patients' ATX-101 volume was similar for both those who met goals and those who did not, but extreme patients who met their goals required 10 mL more than those patients who did not.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Careful patient selection, adequate volume administration, and an appropriate number of treatments (dependent on baseline SMF severity) contribute to successful outcomes with ATX-101.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002092","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:12:10Z","timestamp":1568340730000},"page":"639-645","source":"Crossref","is-referenced-by-count":10,"title":["ATX-101 (Deoxycholic Acid Injection) Leads to Clinically Meaningful Improvement in Submental Fat: Final Data From CONTOUR"],"prefix":"10.1097","volume":"46","author":[{"given":"Kathleen","family":"Behr","sequence":"first","affiliation":[{"name":"Private Practice (Behr Laser & Skin Care Center), Fresno, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen M.","family":"Kavali","sequence":"additional","affiliation":[{"name":"Private Practice (Kavali Plastic Surgery and Skin Renewal Center), Atlanta, Georgia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Munavalli","sequence":"additional","affiliation":[{"name":"Private Practice (Dermatology, Laser & Vein Specialists of the Carolinas), Charlotte, North Carolina;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig F.","family":"Teller","sequence":"additional","affiliation":[{"name":"Private Practice (Bellaire Dermatology Associates), Bellaire, Texas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Yoelin","sequence":"additional","affiliation":[{"name":"Private Practice (Medical Associates, Inc.), Newport Beach, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Breshears","sequence":"additional","affiliation":[{"name":"Evidence Scientific Solutions, Philadelphia, Pennsylvania;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Sangha","sequence":"additional","affiliation":[{"name":"Medical Affairs, Allergan plc, Irvine, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/DSS.0000000000001648","article-title":"Personal (self) perceptions of submental fat among adults in the United States","volume":"45","author":"Baumann","year":"2019","journal-title":"Dermatol Surg"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1068\/p6423","article-title":"Facial adiposity: a cue to health?","volume":"38","author":"Coetzee","year":"2009","journal-title":"Perception"},{"key":"R3-20230829","first-page":"27","article-title":"Perceptions and practices in submental fat treatment: a survey of physicians and patients","volume":"11","author":"Schlessinger","year":"2013","journal-title":"Skinmed"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coms.2008.10.008","article-title":"Complications of neck liposuction and submentoplasty","volume":"21","author":"Koehler","year":"2009","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/01676830601034532","article-title":"Aesthetic surgery of the aging neck: options and techniques","volume":"25","author":"Patel","year":"2006","journal-title":"Orbit"},{"key":"R6-20230829","first-page":"40","article-title":"Final data from the Condition of Submental Fullness and Treatment Outcomes Registry (CONTOUR)","volume":"18","author":"Palm","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jaad.2016.04.028","article-title":"ATX-101 for reduction of submental fat: a phase III randomized controlled trial","volume":"75","author":"Humphrey","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/DSS.0000000000000578","article-title":"REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction","volume":"42","author":"Jones","year":"2016","journal-title":"Dermatol Surg"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/jdv.12377","article-title":"Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study","volume":"28","author":"Ascher","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/bjd.12695","article-title":"Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study","volume":"170","author":"Rzany","year":"2014","journal-title":"Br J Dermatol"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"A412","DOI":"10.1016\/j.jval.2015.09.989","article-title":"Development and validation of a patient-reported outcome measure of the psychological impact of submental fat","volume":"18","author":"Gross","year":"2015","journal-title":"Value Health"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/DSS.0000000000001484","article-title":"Reduction of submental fat continues beyond 28 days after ATX-101 treatment: results from a post hoc analysis","volume":"44","author":"Dover","year":"2018","journal-title":"Dermatol Surg"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/DSS.0000000000000876","article-title":"Facial treatment preferences among aesthetically oriented men","volume":"42","author":"Jagdeo","year":"2016","journal-title":"Dermatol Surg"},{"key":"R18-20230829","first-page":"1001","article-title":"Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution","volume":"30","author":"Rotunda","year":"2004","journal-title":"Dermatol Surg"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4725.2010.01566.x","article-title":"Tissue-selective effects of injected deoxycholate","volume":"36","author":"Thuangtong","year":"2010","journal-title":"Dermatol Surg"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/DSS.0000000000001851","article-title":"Histological analysis of the effect of ATX-101 (deoxycholic acid injection) on subcutaneous fat: results from a phase 1 open-label study","volume":"46","author":"Walker","year":"2020","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T01:04:11Z","timestamp":1693271051000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002092","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}